Skip to content
PICO Portalanswers from OpenAlex

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

PaperCitations, authors & open-access status

Imatinib for refractory chronic graft-versus-host disease with fibrotic features is a paper indexed in PICO Portal from OpenAlex.

How many citations does Imatinib for refractory chronic graft-versus-host disease with fibrotic features have?

PICO Portalcitation count

Imatinib for refractory chronic graft-versus-host disease with fibrotic features has 233 citations in the OpenAlex counts PICO Portal stores.

When was Imatinib for refractory chronic graft-versus-host disease with fibrotic features published?

PICO Portalyear

Imatinib for refractory chronic graft-versus-host disease with fibrotic features has 2009 year in the PICO Portal index.

What is the open-access status of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?

PICO Portaloa status

Imatinib for refractory chronic graft-versus-host disease with fibrotic features has closed oa status in the PICO Portal index.

What is the DOI of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?

PICO Portaldoi

The DOI for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.

What is the PMID of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?

PICO Portalpmid

The PMID for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.

What is the OpenAlex record for Imatinib for refractory chronic graft-versus-host disease with fibrotic features?

PICO Portalopenalex

The OpenAlex for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial